News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,743 Results
Type
Article (10546)
Company Profile (51)
Press Release (215146)
Multimedia
Podcasts (66)
Webinars (12)
Section
Business (77377)
Career Advice (1227)
Deals (12925)
Drug Delivery (61)
Drug Development (13285)
Employer Resources (136)
FDA (3907)
Job Trends (6090)
News (110679)
Policy (9138)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
Academia (721)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (19722)
ALS (26)
Alzheimer's disease (297)
Antibody-drug conjugate (ADC) (34)
Approvals (3915)
Artificial intelligence (159)
Autoimmune disease (7)
Automation (10)
Bankruptcy (72)
Best Places to Work (4727)
BIOSECURE Act (18)
Biosimilars (26)
Biotechnology (41)
Bladder cancer (11)
Brain cancer (3)
Breast cancer (66)
Cancer (534)
Cardiovascular disease (32)
Career advice (1037)
Career pathing (24)
CAR-T (45)
Cell therapy (141)
Cervical cancer (9)
Clinical research (10820)
Collaboration (325)
Compensation (80)
Complete response letters (2)
COVID-19 (596)
CRISPR (13)
C-suite (152)
Cystic fibrosis (35)
Data (456)
Decentralized trials (1)
Denatured (30)
Depression (12)
Diabetes (56)
Diagnostics (2268)
Digital health (10)
Diversity (6)
Diversity, equity & inclusion (30)
Drug discovery (43)
Drug pricing (67)
Drug shortages (13)
Duchenne muscular dystrophy (13)
Earnings (20677)
Editorial (26)
Employer branding (17)
Employer resources (114)
Events (30049)
Executive appointments (491)
FDA (4233)
Featured Employer (22)
Friedreich's ataxia (3)
Frontotemporal dementia (2)
Funding (287)
Gene editing (34)
Generative AI (17)
Gene therapy (95)
GLP-1 (237)
Government (1428)
Guidances (26)
Healthcare (6077)
Huntington's disease (6)
IgA nephropathy (3)
Immunology and inflammation (19)
Indications (8)
Infectious disease (641)
Inflammatory bowel disease (35)
Inflation Reduction Act (9)
Influenza (17)
Intellectual property (33)
Interviews (196)
IPO (4702)
IRA (38)
Job creations (1498)
Job search strategy (896)
Kidney cancer (6)
Labor market (29)
Layoffs (116)
Leadership (15)
Legal (2034)
Liver cancer (16)
Lung cancer (78)
Lymphoma (42)
Machine learning (4)
Management (42)
Manufacturing (175)
MASH (19)
Medical device (4699)
Medtech (4703)
Mergers & acquisitions (8520)
Metabolic disorders (176)
Multiple sclerosis (18)
NASH (1)
Neurodegenerative disease (23)
Neuropsychiatric disorders (6)
Neuroscience (439)
NextGen: Class of 2025 (2737)
Non-profit (1204)
Northern California (767)
Now hiring (15)
Obesity (96)
Opinion (184)
Ovarian cancer (25)
Pain (20)
Pancreatic cancer (16)
Parkinson's disease (35)
Partnered (14)
Patents (78)
Patient recruitment (19)
Peanut (4)
People (32071)
Pharmaceutical (11)
Pharmacy benefit managers (15)
Phase I (3130)
Phase II (4665)
Phase III (4123)
Pipeline (345)
Policy (116)
Postmarket research (422)
Preclinical (1464)
Press Release (54)
Prostate cancer (20)
Psychedelics (10)
Radiopharmaceuticals (116)
Rare diseases (109)
Real estate (2912)
Recruiting (58)
Regulatory (6238)
Reports (27)
Research institute (802)
Resumes & cover letters (198)
RNA editing (2)
RSV (9)
Schizophrenia (22)
Series A (57)
Series B (29)
Service/supplier (4)
Sickle cell disease (10)
Southern California (607)
Special edition (9)
Spinal muscular atrophy (33)
Sponsored (17)
Startups (1512)
State (1)
Stomach cancer (3)
Supply chain (40)
Tariffs (28)
The Weekly (35)
United States (6750)
Vaccines (125)
Venture capitalists (21)
Weight loss (71)
Women's health (16)
Worklife (13)
Date
Today (67)
Last 7 days (204)
Last 30 days (825)
Last 365 days (10442)
2025 (3213)
2024 (11139)
2023 (13057)
2022 (19887)
2021 (20172)
2020 (19139)
2019 (18733)
2018 (13946)
2017 (11199)
2016 (10557)
2015 (11889)
2014 (8579)
2013 (7551)
2012 (8758)
2011 (8973)
2010 (7419)
Location
Africa (362)
Alabama (13)
Alaska (4)
Arizona (83)
Arkansas (5)
Asia (15469)
Australia (2121)
California (1710)
Canada (662)
China (180)
Colorado (77)
Connecticut (93)
Delaware (37)
Europe (30703)
Florida (282)
Georgia (54)
Idaho (24)
Illinois (218)
India (13)
Indiana (102)
Iowa (6)
Japan (57)
Kansas (33)
Kentucky (8)
Louisiana (7)
Maine (12)
Maryland (212)
Massachusetts (1148)
Michigan (110)
Minnesota (110)
Mississippi (2)
Missouri (22)
Montana (6)
Nebraska (15)
Nevada (17)
New Hampshire (40)
New Jersey (561)
New Mexico (10)
New York (630)
North Carolina (349)
North Dakota (5)
Northern California (767)
Ohio (90)
Oklahoma (10)
Oregon (8)
Pennsylvania (335)
Puerto Rico (4)
Rhode Island (12)
South America (530)
South Carolina (15)
Southern California (607)
Tennessee (27)
Texas (229)
Utah (60)
Virginia (33)
Washington D.C. (19)
Washington State (94)
West Virginia (3)
Wisconsin (29)
225,743 Results for "evonik industries".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Evonik to Lay Off Additional Employees, Cutting up to 260 in Germany
Evonik’s latest layoffs are tied to discontinuing production of keto acids in Hanau, Germany, by the end of next year. Earlier this year, news broke the company is also cutting up to 2,000 employees globally by 2026.
October 14, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development
December 18, 2024
·
3 min read
FDA
FDA Moves to Restrict Industry Influence on Advisory Committees
Industry representatives will still be allowed at these meetings, but they will no longer have a spot on the advisory committee.
April 18, 2025
·
2 min read
·
Tristan Manalac
Pharm Country
Modern Meadow and Evonik Join Forces to Revolutionize Clean Beauty with Animal-Free Collagen
Modern Meadow announced a groundbreaking partnership with Evonik, a leader in specialty ingredients for the beauty and personal care industry, to create sustainable, clean beauty products that are high-quality and animal-free.
May 2, 2023
·
3 min read
Government
HHS Secretary Kennedy Accuses FDA Employees of Being Industry ‘Sock Puppet’
Leerink analysts warned that Kennedy’s remarks to FDA staff would likely be a negative for the biotech industry.
April 14, 2025
·
2 min read
·
Tristan Manalac
Policy
Trump’s Whiplash Tariffs and HHS Layoffs Set Biopharma Industry Ablaze
As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, regulators and many others speak out.
April 11, 2025
·
3 min read
·
BioSpace Editorial Staff
FDA
Banning Industry From FDA Adcomms Won’t ‘Move the Needle Much’ in Makary, RFK’s Fight Against COIs
FDA Commissioner Marty Makary last week announced a directive that would limit industry participation in the agency’s advisory committees. But not only do company reps serve only as non-voting members, a 1997 law actually requires industry involvement.
April 21, 2025
·
5 min read
·
Heather McKenzie
Drug Development
Diversity at the Forefront: Life Sciences Industry Champions Inclusive Representation
The industry remains unwavering in the commitment to increased clinical trial accessibility and representation.
February 25, 2025
·
1 min read
·
Lori Ellis
Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
Evonik and BellaSeno, a developer of 3D-printed absorbable scaffolds, are working together to commercialize innovative 3D-printed scaffolds for bone regeneration.
March 6, 2023
·
4 min read
In partnership with GenScript
Beyond the Breakthrough: Industry Leaders Address Key Hurdles Facing Cell and Gene Therapies
At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ongoing challenges in manufacturing, distribution, treatment center capacity, and global payment structures for cell and gene therapies.
April 14, 2025
·
6 min read
·
BioSpace Insights
1 of 22,575
Next
